Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: This study explored co-receptor usage and prediction of V3 genotyping algorithms in HIV-1 subtype B' from paid blood donors experienced anti-retroviral therapy in Chinese central province in order to design effectively therapeutic regimen.
Methods: HIV-1 strains were isolated in treatment HIV-1 infections and treatment-naïve HIV-1 infections, then co-receptor usage of HIV-1 strains was identified based on Ghost cell lines using flow cytometry. HIV-1 V3 region was amplified and submitted into web-server (WebPSSM and geno2pheno) to predict HIV-1 co-receptor usage. The feasibility of prediction HIV-1 usage with Web-server assay was analyzed by comparing prediction of V3 genotyping algorithms with HIV phenotype assay based on Ghost cell line.
Results: 45 HIV-1 strains and 114 HIV-1 strains were isolated from HIV-1 infections exposed anti-retroviral therapy and treatment-naïve, respectively. 41% clinical viruses from ART patients and 18% from treatment-naïve patients used CXCR4 as co-receptor. The net charge in the V3 loop was significantly difference in both groups. The sensitivity and specificity for predicting co-receptor capacity is 54.6% and 90.0% on 11/25 rule, 50.0% and 90% on Web-PSSM(x4r5), 68.2% and 40.0% on Geno2pheno[co-receptor].
Conclusion: Dual/mixed/X4 co-receptor utilization was higher in ART patients than treatment-naïve patients. It is should paid attention to predicting HIV-1 co-receptor usage based on V3 genotyping algorithms in HIV-1 subtype B' from paid blood donors experienced anti-retroviral therapy in Chinese central province.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988017 | PMC |
| http://dx.doi.org/10.1186/1743-422X-7-280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prediction of the Co-receptor usage of the main worldwide HIV-1 subtypes, CRF, and CRF35-AD in Iranian patients via the five genotypic tools.
Biochem Biophys Rep
March 2025
HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
HIV-1 has various subtypes and CRFs, each with unique genetic attributes that impact the virus's spread, disease development, and response to treatment in different populations. Determining V3 tropism is crucial for utilizing CCR5 antagonists and understanding why certain HIV-1 subtypes are more pathogenic than others are. Genotypic coreceptor usage of 603 major subtypes of A, B, C, AE, and CRF35-AD is investigated via five bioinformatics tools (PhenoSeq, WebPSSM, Geno2Pheno, Net charge, and the 11/25 rule).
View Article and Find Full Text PDFVirulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation.
Viruses
November 2024
Department of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Article Synopsis
- The study explored the biological features of early transmitted/founder (T/F) HIV variants from recently infected infants to improve treatment and vaccine strategies.
- The researchers created 18 full-length infectious molecular clones (IMCs) of HIV and performed genetic and functional analyses to assess their infectivity and response to treatments.
- Results showed that while some T/F variants carried a drug resistance mutation, they still maintained the ability to spread and were susceptible to certain therapeutic approaches, indicating potential pathways for effective interventions.
Phenotypic Characterization of Subtype A and Recombinant AC Transmitted/Founder Viruses from a Rwandan HIV-1 Heterosexual Transmission Cohort.
Viruses
October 2024
Emory Vaccine Center, Emory National Primate Research Center, Atlanta, GA 30329, USA.
HIV-1 subtypes have distinct geographical distributions, with subtypes A, C, and D and inter-subtype recombinants circulating in sub-Saharan Africa. Historically, individuals living with subtype A viruses exhibit slower CD4 decline and progression to AIDS diagnosis. Despite this, there are few authentic infectious molecular clones (IMCs) of subtype A or AC recombinant transmitted founder (TF) viruses with which to investigate viral impacts on pathogenesis.
View Article and Find Full Text PDFSolving technical issues in flow cytometry to characterize porcine CD8α/β expressing lymphocytes.
Vet Immunol Immunopathol
December 2024
Christian Doppler Laboratory for Optimized Prediction of Vaccination Success in Pigs, Immunology, Department of Biological Sciences and Pathobiology, University of VeterinaryMedicine Vienna, Vienna, Austria; Immunology, Department of Biological Sciences and Pathobiology, University of Veterinary
Article Synopsis
- The CD8 molecule is a crucial receptor on T cells that interacts with major histocompatibility complex class I to recognize antigens, composed of two chains (α and β).
- In pigs, CD8 is found on various lymphocytes, mostly as αα homodimers or αβ heterodimers in cytolytic T cells.
- The study identified issues with certain monoclonal antibodies in multi-color flow cytometry, highlighting that one specific CD8α clone shouldn't be used with two CD8β clones to avoid inaccurate results, while another CD8α clone showed no inhibition and is recommended for future experiments.
Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4 T-cells.
J Neurovirol
August 2024
Translational Virology, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.
Article Synopsis
- HIV persists in the central nervous system (CNS) of people living with HIV, leading to cognitive impairments even with antiretroviral therapy (ART).
- Researchers analyzed paired cerebrospinal fluid (CSF) and blood samples from 19 untreated adults, finding higher HIV RNA levels in plasma compared to CSF and mostly consistent coreceptor usage.
- The study revealed that some viruses in the CNS can replicate in microglia (brain immune cells) as well as T-cells, suggesting that viral evolution may help the infection spread within the CNS, which needs further investigation.